Copyright
©The Author(s) 2023.
World J Crit Care Med. Jan 9, 2023; 12(1): 1-9
Published online Jan 9, 2023. doi: 10.5492/wjccm.v12.i1.1
Published online Jan 9, 2023. doi: 10.5492/wjccm.v12.i1.1
Table 1 Basic characteristics, clinical parameters and hospital course
Patient parameters | Overall (n = 71), % | Meningitis group (n = 23) , % | Non-Meningitis Group (n = 48), % | P value |
Age, yr | 58.1 ± 16 | 57.8 ± 15.4 | 58.9 ± 17.3 | 0.820 |
Males | 23 (32.4) | 10 (43.5) | 13 (27.1) | 0.167 |
Clinical parameters | ||||
Headache | 25 (35.2) | 11 (47.8) | 14 (29.2) | 0.123 |
Seizures | 46 (64.8) | 17 (73.9) | 29 (60.4) | 0.265 |
Fever | 50 (70.4) | 16 (69.6) | 34 (70.8) | 0.871 |
Altered sensorium | 70 (98.6) | 23 (100) | 47 (97.9) | 0.486 |
Photophobia | 5 (7) | 3 (13) | 2 (4) | 0.171 |
Coma | 24 (33.8) | 9 (39.1) | 15 (31.3) | 0.511 |
Antibiotic exposure before CSF analysis | 65 (91.5) | 22 (95.7) | 43 (89.6) | 0.39 |
Traumatic brain injury | 2 (3) | 0 (0) | 2 (4) | 0.321 |
Neurosurgical intervention | 4 (5.6) | 3 (13) | 1 (2) | 0.061 |
Neurosurgical device in-situ | 4 (5.6) | 3 (13) | 1 (2) | 0.061 |
Glasgow coma scale | 9.5 ± 4 | 9 ± 4 | 9.7 ± 4 | 0.508 |
Neck stiffness | 4 (5.6) | 4 (17.4) | 0 (0) | 0.003a |
Focal neurological deficit | 14 (19.7) | 5 (21.7) | 9 (18.8) | 0.767 |
Length of stay in hospital | 21.1 ± 16 | 21.9 ± 8.9 | 21 ± 18.2 | 0.053 |
Length of stay in ICU | 10.4 + 8.9 | 12.1 ± 6.3 | 9.6 ± 9.8 | 0.005a |
Need for any surgical intervention | 20 (28.2) | 10 (43.5) | 10 (20.8) | 0.047a |
Need for invasive mechanical ventilation | 27 (38) | 13 (56.5) | 14 (29.2) | 0.026a |
ICU mortality | 20 (28.2) | 10 (43.5) | 10 (20.8) | 0.047a |
Table 2 Comparison of cerebrospinal fluid analysis between meningitis and non-meningitis groups
CSF parameters | Meningitis group (n = 23) | Non-meningitis group (n = 48) | P value |
TLC (mean ± SD) | 1223.4 ± 2611 | 8.1 ± 12.6 | < 0.001a |
Protein (mean ± SD) | 177.1 ± 204.2 | 69.3 ± 61.5 | 0.002a |
Sugar mg/dL (mean ± SD) | 90.1 ± 98.4 | 102.1 ± 41 | 0.011a |
Lactate levels mg/dL (mean ± SD) | 60 ± 43.9 | 23.6 ± 11.1 | < 0.001a |
Lactate levels mmol/L (mean ± SD) | 6.6 ± 4.8 | 2.6 ± 1.2 | < 0.001a |
Positive CSF cultures | 17 (74) | 0 (0) | < 0.001a |
Positive meningo-encephalitis panel | 7 (30) | 0 (0) | 0.001a |
Positive CSF cultures or meningo-encephalitis panel | 23 (100) | 0 (0) | < 0.001a |
Table 3 Comparison of various cerebrospinal fluid parameters for diagnosing meningitis
CSF Parameters | Cut-off | Sensitivity, % | Specificity, % | NPV, % | PPV, % | Accuracy, % | AUC | CI | P value |
TLC (Cell/mm3) | > 55 | 73.9 | 100 | 100 | 88.9 | 91.5 | 0.92 | 0.84-1 | < 0.001a |
Lactate levels (mmol/L) | > 2.7 | 82.6 | 72.9 | 59.4 | 89.7 | 76.1 | 0.81 | 0.7-0.9 | < 0.001a |
Protein (mg/dL) | > 104.4 | 56.5 | 87.5 | 68.4 | 80.8 | 77.5 | 0.73 | 0.6-0.9 | 0.002a |
Sugar (mg/dL) | > 63 | 56.5 | 83.3 | 61.9 | 80.0 | 74.6 | 0.7 | 0.6-0.9 | 0.006a |
Table 4 Etiological causes of patients in meningitis and non-meningitis groups
Meningitis group (n = 23), % | ||
Bacterial (n = 12) | Streptococcus pyogenes | 5 (41.7) |
Staphylococcus aureus | 2 (16.7) | |
Haemophilus influenzae | 2 (16.7) | |
Enterococcus faecium | 2 (16.7) | |
Escherichia coli | 1 (8.4) | |
Viral (n = 6) | Varicella zoster virus | 3 (27.3) |
Herpes simplex virus | 2 (18.2) | |
Measles virus | 1 (9.1) | |
Fungal (n = 2) | Candida tropicalis | 1 (9.1) |
Cryptococcus neoformans | 1 (9.1) | |
Tubercular (n = 3) | Mycobacterium tuberculosis complex | 3 (27.3) |
Non-meningitis group (n = 48) | ||
Septic and metabolic encephalopathy | 34 (70.8) | |
Hypoxic brain injury | 3 (6.3) | |
Guillain barre syndrome | 2 (4.2) | |
Autoimmune encephalitis | 2 (4.2) | |
Metastatic brain involvement | 2 (4.2) | |
Post-ictal confusion | 2 (2.1) | |
Hypoglycaemic coma | 1 (2.1) | |
Demyelinating disorder | 1 (2.1) | |
Unknown | 1 (2.1) |
- Citation: Yadav D, Singh O, Juneja D, Goel A, Kataria S, Beniwal A. Role of cerebrospinal fluid lactate in diagnosing meningitis in critically ill patients. World J Crit Care Med 2023; 12(1): 1-9
- URL: https://www.wjgnet.com/2220-3141/full/v12/i1/1.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v12.i1.1